Amedica revises $6 million senior convertible note sold to MG Partners

Company extends maturity, lowers conversion price to $1.00 per share

By Devika Patel

Knoxville, Tenn., April 6 – Amedica Corp. amended the terms of its $6.4 million senior convertible notes on April 2, according to an 8-K filed Monday with the Securities and Exchange Commission. The notes were sold in a private placement with MG Partners II Ltd. on June 30, 2014.

The 6% convertibles’ maturity date may now be extended to June 30, 2017 from June 30, 2016 if the company satisfies certain equity conditions. The notes will now be convertible into common stock at $1.00 per share, a 78.5% discount to the June 27 closing share price (Nasdaq: AMDA) of $4.65. The notes originally were convertible into stock at $3.75 per share, a 19.36% discount to the June 27 closing share price.

The commercial biomaterial company is based in Salt Lake City.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.